These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1175 related articles for article (PubMed ID: 24477973)

  • 1. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.
    Park TS; Goldberg IJ
    Heart Fail Clin; 2012 Oct; 8(4):633-41. PubMed ID: 22999245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
    Hölscher ME; Bode C; Bugger H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.
    Bayeva M; Sawicki KT; Ardehali H
    J Am Heart Assoc; 2013 Nov; 2(6):e000433. PubMed ID: 24275630
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.
    Al Kury LT
    J Diabetes Res; 2020; 2020():1942086. PubMed ID: 33274235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Cardiovascular Disease in Diabetes.
    Haas AV; McDonnell ME
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):51-63. PubMed ID: 29407056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
    Hensel KO
    Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
    Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetic cardiomyopathy.
    Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
    Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in diabetes.
    Jankauskas SS; Kansakar U; Varzideh F; Wilson S; Mone P; Lombardi A; Gambardella J; Santulli G
    Metabolism; 2021 Dec; 125():154910. PubMed ID: 34627874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
    Packer M
    Diabetes Obes Metab; 2019 Aug; 21(8):1765-1768. PubMed ID: 31144444
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
    Russell J; Du Toit EF; Peart JN; Patel HH; Headrick JP
    Cardiovasc Diabetol; 2017 Dec; 16(1):155. PubMed ID: 29202762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
    Ussher JR
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Cardiomyopathy.
    Dillmann WH
    Circ Res; 2019 Apr; 124(8):1160-1162. PubMed ID: 30973809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
    Yue Y; Meng K; Pu Y; Zhang X
    Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
    Knapp M; Tu X; Wu R
    Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis of Cardiomyopathies in Type 2 Diabetes.
    Giardinelli S; Meliota G; Mentino D; D'Amato G; Faienza MF
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Mikami A; Ogino A; Watanabe T; Morishita K; Okada H; Kawasaki M; Seishima M; Minatoguchi S
    Autophagy; 2015; 11(7):1146-60. PubMed ID: 26042865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.